Insider trade report
Open the filing on sec.gov
Embecta Corp. (EMBC)
Nasdaq: EMBC · Surgical & Medical Instruments & Apparatus · Wilmington, DE · filing with the SEC since 2021
The companyfiscal 2025, as filed
Revenue$1.08B-3.8%
Net income$95.4M+21.8%
Earnings per share$1.62+20.9%
Operating cash flow$192M+437.0%
Cash$229M-16.6%
Debt$1.39B-11.3%
Shareholders’ equity-$651M+11.9%
Shares, diluted58.9M+1.0%
Return on equityn/a
The recordfrom its filings
Filings in 202635
Newest filingSep 8 · 4
Annual reportNov 25, 2025
Quarterly reportAug 7, 2026
Next report due10-K by Nov 29
Insider sales, 12 months$0.00
Insider buys, 12 months$600,000
Patents granted36
Filer categoryLarge accelerated filer
Trailing twelve months to Jun 2026Revenue $1.02BNet income $87.5MCash from operations $174Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
As filed, in USD. Nothing here is a forecast.
News
Notice of intended sale
Open the filing on sec.gov
Large holder update, amended
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Insider trade report
Open the filing on sec.gov
Quarterly report
Open the filing on sec.gov
Results released
Open the filing on sec.gov
Nothing of this kind is on the record for this company yet.
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.